Michel Billiard, MD. "Idiopathic Hypersomnia". Sleep Disorders I. Gui-de-Chauliac Hospital, Neurology B Department, 34295 Montpellier, Cedex 05, France. ص. 573–582. مؤرشف من الأصل في 2017-10-23.
Dauvilliers, Yves؛ وآخرون (1 أبريل 2006). "Differential Diagnosis in Hypersomnia". Current Neurology and Neuroscience Reports. Current Medicine Group. ج. 6 ع. 2: 156–162. DOI:10.1007/s11910-996-0039-2. PMID:16522270.
Bassetti، C (1997). "Idiopathic hypersomnia A series of 42 patients". Brain. ج. 120 ع. 8: 1423–1435. DOI:10.1093/brain/120.8.1423.
Bendrich Roth, MD؛ Sonia Nevsimalova, MD؛ Allan Rechtschaffen (مايو 1972). "Hypersomnia With "Sleep Drunkenness"". Arch Gen Psychiatry. ج. 26 ع. 5: 456–462. DOI:10.1001/archpsyc.1972.01750230066013. PMID:5019884.
Vernet C، Leu-Semenescu S، Buzare MA، Arnulf I (2010). "Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness". Journal of Sleep Research. ج. 19 ع. 4: 525–534. DOI:10.1111/j.1365-2869.2010.00824.x. PMID:20408941.
Billiard، M.؛ Dauvilliers، Y. (أكتوبر 2001). "Idiopathic Hypersomnia". Sleep Med Rev. ج. 5 ع. 5: 349–358. DOI:10.1053/smrv.2001.0168. PMID:12530998.
D.B. Rye؛ D.L. Bliwise؛ K. Parker؛ L.M. Trotti؛ P. Saini؛ J. Fairley؛ A. Freeman؛ P.S. Garcia؛ M.J. Owens؛ J.C. Ritchie؛ A. Jenkins (2012). "Modulation of Vigilance in the Primary Hypersomnias by Endogenous Enhancement of GABAA Receptors". Sci. Transl. Med. ج. 4 ع. 161: 161ra151. DOI:10.1126/scitranslmed.3004685. PMID:23175709.
Montplaisir J، Fantini L (2001). "Idiopathic hypersomnia: a diagnostic dilemma. A commentary of "Idiopathic hypersomnia" (M. Billiard and Y. Dauvilliers)". Sleep Med Rev. ج. 5 ع. 5: 361–362. DOI:10.1053/smrv.2001.0216. PMID:12530999.
Adenuga، Olufemi؛ Attarian، Hrayr (2014). "Treatment of Disorders of Hypersomnolence". Current Treatment Options in Neurology. ج. 16 ع. 9. DOI:10.1007/s11940-014-0302-9. ISSN:1092-8480.
Ishizuka T، Murakami M، Yamatodani A (يناير 2008). "Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats". Eur. J. Pharmacol. ج. 578 ع. 2–3: 209–15. DOI:10.1016/j.ejphar.2007.09.009. PMID:17920581.
E. Kelty؛ V. Martyn؛ G. O’Neil؛ G. Hulse (19 فبراير 2014). "Use of subcutaneous flumazenil preparations for the treatment of idiopathic hypersomnia: A case report". Journal of Psychopharmacology. ج. 28: 703–706. DOI:10.1177/0269881114523865. PMID:24554692.
Trotti, L؛ وآخرون (3 ديسمبر 2013). "Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience". Journal of Psychopharmacology. ج. 28 ع. 7: 697–702. DOI:10.1177/0269881113515062. PMID:24306133.
Gosmany M (1998). "The influence of clinical symptoms on quality of life in patients with narcolepsy". Neurology. ج. 50: S31–6. DOI:10.1212/wnl.50.2_suppl_1.s31.
Mallampalli، Monica P.؛ Carter، Christine L. (2014). "Exploring Sex and Gender Differences in Sleep Health: A Society for Women's Health Research Report". Journal of Women's Health. ج. 23 ع. 7: 553–562. DOI:10.1089/jwh.2014.4816. ISSN:1540-9996.
Bayon V، Léger D، Philip P (2009). "Socio-professional handicap and accidental risk in patients with hypersomnias of central origin". Sleep Med Rev. ج. 13 ع. 6: 421–426. DOI:10.1016/j.smrv.2009.02.001. PMID:19493688.
Dauvilliers, Yves؛ وآخرون (1 أبريل 2006). "Differential Diagnosis in Hypersomnia". Current Neurology and Neuroscience Reports. Current Medicine Group. ج. 6 ع. 2: 156–162. DOI:10.1007/s11910-996-0039-2. PMID:16522270.
Bendrich Roth, MD؛ Sonia Nevsimalova, MD؛ Allan Rechtschaffen (مايو 1972). "Hypersomnia With "Sleep Drunkenness"". Arch Gen Psychiatry. ج. 26 ع. 5: 456–462. DOI:10.1001/archpsyc.1972.01750230066013. PMID:5019884.
Vernet C، Leu-Semenescu S، Buzare MA، Arnulf I (2010). "Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness". Journal of Sleep Research. ج. 19 ع. 4: 525–534. DOI:10.1111/j.1365-2869.2010.00824.x. PMID:20408941.
Billiard، M.؛ Dauvilliers، Y. (أكتوبر 2001). "Idiopathic Hypersomnia". Sleep Med Rev. ج. 5 ع. 5: 349–358. DOI:10.1053/smrv.2001.0168. PMID:12530998.
D.B. Rye؛ D.L. Bliwise؛ K. Parker؛ L.M. Trotti؛ P. Saini؛ J. Fairley؛ A. Freeman؛ P.S. Garcia؛ M.J. Owens؛ J.C. Ritchie؛ A. Jenkins (2012). "Modulation of Vigilance in the Primary Hypersomnias by Endogenous Enhancement of GABAA Receptors". Sci. Transl. Med. ج. 4 ع. 161: 161ra151. DOI:10.1126/scitranslmed.3004685. PMID:23175709.
Montplaisir J، Fantini L (2001). "Idiopathic hypersomnia: a diagnostic dilemma. A commentary of "Idiopathic hypersomnia" (M. Billiard and Y. Dauvilliers)". Sleep Med Rev. ج. 5 ع. 5: 361–362. DOI:10.1053/smrv.2001.0216. PMID:12530999.
Ishizuka T، Murakami M، Yamatodani A (يناير 2008). "Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats". Eur. J. Pharmacol. ج. 578 ع. 2–3: 209–15. DOI:10.1016/j.ejphar.2007.09.009. PMID:17920581.
E. Kelty؛ V. Martyn؛ G. O’Neil؛ G. Hulse (19 فبراير 2014). "Use of subcutaneous flumazenil preparations for the treatment of idiopathic hypersomnia: A case report". Journal of Psychopharmacology. ج. 28: 703–706. DOI:10.1177/0269881114523865. PMID:24554692.
Trotti, L؛ وآخرون (3 ديسمبر 2013). "Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience". Journal of Psychopharmacology. ج. 28 ع. 7: 697–702. DOI:10.1177/0269881113515062. PMID:24306133.
Bayon V، Léger D، Philip P (2009). "Socio-professional handicap and accidental risk in patients with hypersomnias of central origin". Sleep Med Rev. ج. 13 ع. 6: 421–426. DOI:10.1016/j.smrv.2009.02.001. PMID:19493688.
Michel Billiard, MD. "Idiopathic Hypersomnia". Sleep Disorders I. Gui-de-Chauliac Hospital, Neurology B Department, 34295 Montpellier, Cedex 05, France. ص. 573–582. مؤرشف من الأصل في 2017-10-23.
Mallampalli، Monica P.؛ Carter، Christine L. (2014). "Exploring Sex and Gender Differences in Sleep Health: A Society for Women's Health Research Report". Journal of Women's Health. ج. 23 ع. 7: 553–562. DOI:10.1089/jwh.2014.4816. ISSN:1540-9996.